Corticosteroids and Pregnancy

 

 Buy Article Permissions and Reprints

ABSTRACT

Pregnancy results in major changes in the hypothalamo-pituitary-adrenal (HPA) axis, which in turn influence fetal growth and the timing of labor. From the beginning of the second trimester maternal cortisol secretion increases, and in late pregnancy the placenta, in large part mediated through corticotroph-releasing hormone, plays a crucial role in the regulation of the fetal HPA axis to ensure the synchronization of the various processes involved in parturition. Exposure of the fetus to excess glucocorticoid results in intrauterine growth failure and possibly "programs" the development of cardiovascular disease in adult life. Biochemical assessment of the HPA axis is complicated by the estrogen-induced elevation of circulating cortisol-binding globulin, resulting in misleadingly high circulating cortisol levels The hypercortisolemia of Cushing's syndrome causes infertility, but if pregnancy does occur it can result in increased morbidity and mortality in mother and fetus. However, the prospects of a successful pregnancy are greatly improved with control of hypercortisolemia by surgery and medical therapy with metyrapone. Hypoadrenalism can be difficult to diagnose during pregnancy but, once the diagnosis is made, with careful monitoring, dose adjustment as indicated, and parenteral cover for labor, a successful pregnancy should result.

REFERENCES

• 1 Seckl J R, Cleasby M, Nyirenda M J. Glucocorticoids, 11beta-hydroxysteroid dehydrogenase, and fetal programming.  Kidney Int . 2000;  57 1412-1417
  CrossrefPubMedGoogle Scholar
• 2 Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin.  Science . 1981;  213 1394-1397
  CrossrefPubMedGoogle Scholar
• 3 Petraglia F, Sawchenko P E, Rivier J, Vale W. Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta.  Nature . 1987;  328 717-719
  CrossrefPubMedGoogle Scholar
• 4 Barker D J, Osmond C, Golding J, Kuh D, Wadsworth M E. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease.  BMJ . 1989;  298 564-567
  CrossrefPubMedGoogle Scholar
• 5 Barker D J, Winter P D, Osmond C, Margetts B, Simmonds S J. Weight in infancy and death from ischaemic heart disease.  Lancet . 1989;  2 577-580
  PubMedGoogle Scholar
• 6 Benediktsson R, Lindsay R S, Noble J, Seckl J R, Edwards C R. Glucocorticoid exposure in utero: new model for adult hypertension.  Lancet . 1993;  341 339-341
  CrossrefPubMedGoogle Scholar
• 7 Gitau R, Fisk N M, Teixeira J M, Cameron A, Glover V. Fetal hypothalamic-pituitary-adrenal stress responses to invasive procedures are independent of maternal responses.  J Clin Endocrinol Metab . 2001;  86 104-109
  CrossrefPubMedGoogle Scholar
• 8 Stewart P M, Corrie J E, Shackleton C H, Edwards C R. Syndrome of apparent mineralocorticoid excess: a defect in the cortisol-cortisone shuttle.  J Clin Invest . 1988;  82 340-349
  CrossrefPubMedGoogle Scholar
• 9 Stewart P M, Rogerson F M, Mason J I. Type 2 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal adrenal steroidogenesis.  J Clin Endocrinol Metab . 1995;  80 885-890
  CrossrefPubMedGoogle Scholar
• 10 Lindsay R S, Lindsay R M, Waddell B J, Seckl J R. Prenatal glucocorticoid exposure leads to offspring hyperglycaemia in the rat: studies with the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone.  Diabetologia . 1996;  39 1299-1305
  CrossrefPubMedGoogle Scholar
• 11 Reinisch J M, Simon N G, Karow W G, Gandelman R. Prenatal exposure to prednisone in humans and animals retards intrauterine growth.  Science . 1978;  202 436-438
  CrossrefPubMedGoogle Scholar
• 12 Liggins G C, Howie R N. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants.  Pediatrics . 1972;  50 515-525
  PubMedGoogle Scholar
• 13 Howie R N. Pharmacological acceleration of lung maturation. In: Villee CA, Villee DB, Zuckerman J, eds. Respiratory Distress Syndrome London: Academic Press 1973: 385-396
  Google Scholar
• 14 New M I, Carlson A, Obeid J. Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies.  J Clin Endocrinol Metab . 2001;  86 5651-5457
  CrossrefPubMedGoogle Scholar
• 15 Lado-Abeal J, Rodriguez-Arnao J, Newell-Price J D. Menstrual abnormalities in women with Cushing's disease are correlated with hypercortisolemia rather than raised circulating androgen levels.  J Clin Endocrinol Metab . 1998;  83 3083-3088
  CrossrefPubMedGoogle Scholar
• 16 Aron D C, Schnall A M, Sheeler L R. Spontaneous resolution of Cushing's syndrome after pregnancy.  Am J Obstet Gynecol . 1990;  162 472-474
  PubMedGoogle Scholar
• 17 Chico A, Manzanares J M, Halperin I, Martinez de Osaba J M, Adelantado J, Webb S M. Cushing's disease and pregnancy: report of six cases.  Eur J Obstet Gynecol Reprod Biol . 1996;  64 143-146
  CrossrefPubMedGoogle Scholar
• 18 Newell-Price J, Trainer P J, Besser M, Grossman A. The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states.  Endocr Rev . 1998;  19 647-672
  CrossrefPubMedGoogle Scholar
• 19 Ross R J, Chew S L, Perry L, Erskine K, Medbak S, Afshar F. Diagnosis and selective cure of Cushing's disease during pregnancy by transsphenoidal surgery.  Eur J Endocrinol . 1995;  132 722-726
  PubMedGoogle Scholar
• 20 Trainer P J, Lawrie H S, Verhelst J. Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment.  Clin Endocrinol . 1993;  38 73-78
  CrossrefPubMedGoogle Scholar
• 21 Aron D C, Schnall A M, Sheeler L R. Cushing's syndrome and pregnancy.  Am J Obstet Gynecol . 1990;  162 244-252
  PubMedGoogle Scholar
• 22 Gormley M J, Hadden D R, Kennedy T L, Montgomery D A, Murnaghan G A, Sheridan B. Cushing's syndrome in pregnancy: treatment with metyrapone.  Clin Endocrinol . 1982;  16 283-293
  PubMedGoogle Scholar
• 23 Close C F, Mann M C, Watts J F, Taylor K G. ACTH-independent Cushing's syndrome in pregnancy with spontaneous resolution after delivery: control of the hypercortisolism with metyrapone.  Clin Endocrinol (Oxf) . 1993;  39 375-379
  PubMedGoogle Scholar
• 24 Wallace C, Toth E L, Lewanczuk R Z, Siminoski K. Pregnancy-induced Cushing's syndrome in multiple pregnancies.  J Clin Endocrinol Metab . 1996;  81 15-21
  CrossrefPubMedGoogle Scholar
• 25 Hana V, Dokoupilova M, Marek J, Plavka R. Recurrent ACTH-independent Cushing's syndrome in multiple pregnancies and its treatment with metyrapone.  Clin Endocrinol (Oxf) . 2001;  54 277-281
  CrossrefPubMedGoogle Scholar
• 26 Naing S, Wieringa G, Perry L A. What value do cortisol measurements provide in monitoring metyrapone therapy?. British Endocrine Societies, Harrogate, April 2002
  Google Scholar
• 27 Verhelst J A, Trainer P J, Howlett T A. Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome.  Clin Endocrinol . 1991;  35 169-178
  CrossrefPubMedGoogle Scholar
• 28 Sonino N, Boscaro M, Paoletta A, Mantero F, Ziliotto D. Ketoconazole treatment in Cushing's syndrome: experience in 34 patients.  Clin Endocrinol . 1991;  35 347-352
  CrossrefPubMedGoogle Scholar
• 29 Zollner E, Delport S, Bonnici F. Fatal liver failure due to ketoconazole treatment of a girl with Cushing's syndrome.  J Pediatr Endocrinol Metab . 2001;  14 335-338
  PubMedGoogle Scholar
• 30 Berwaerts J, Verhelst J, Mahler C, Abs R. Cushing's syndrome in pregnancy treated by ketoconazole: case report and review of the literature.  Gynecol Endocrinol . 1999;  13 175-182
  PubMedGoogle Scholar
• 31 George L D, Selvaraju R, Reddy K, Stout T V, Premawardhana L D. Vomiting and hyponatraemia in pregnancy.  Br J Obstet Gynaecol . 2000;  107 808-809
  PubMedGoogle Scholar
• 32 McGill I G. Addison's disease presenting as a crisis in the puerperium.  Br Med J . 1971;  2 566
  PubMedGoogle Scholar
• 33 Goldman M H, Sfedu E, Aboul-Hosn H, Nutt R. Addison's disease presenting in the postpartum state.  J Med Soc N J . 1983;  80 1030-1031
  PubMedGoogle Scholar
• 34 McLean M, Smith R. Corticotropin-releasing hormone in human pregnancy and parturition.  Trends Endocrinol Metab . 1999;  10 174-178
  PubMedGoogle Scholar